Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several ways. Wh...
Auteurs principaux: | Phillips, W, Christadoss, P, Losen, M, Punga, A, Shigemoto, K, Verschuuren, J, Vincent, A |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Academic Press Inc.
2015
|
Documents similaires
-
Myasthenia gravis with MuSK antibodies
par: Farrugia, M, et autres
Publié: (2005) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
par: Koneczny, I, et autres
Publié: (2014) -
The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
par: Koneczny, I, et autres
Publié: (2014) -
Potential mechanisms in MuSK-myasthenia gravis
par: Koneczny, I
Publié: (2014) -
MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
par: Shalini Bhaskar, et autres
Publié: (2022-01-01)